ProTom International Signed a Strategic Distribution and Licensing Agreement to Distribute with GHGK in China

ProTom International Signed a Strategic Distribution and Licensing Agreement to Distribute with GHGK in China
News provided by
Share this article
Share this article
WAKEFIELD, Mass., Jan. 11, 2021 /PRNewswire/ -- ProTom International Holding Corporation ("ProTom") is pleased to announce that it has signed a distribution and licensing agreement with Guohong Guokang (Beijing) Health Technology Development Co., LTD ("GHGK") who, along with its affiliates, is one of the leading comprehensive high-tech innovative enterprises in China for an exclusive distribution and licensing Agreement to distribute ProTom's Radiance 330® Proton Therapy System in mainland China. The signing of this agreement marks an important milestone for improving the clinical outcomes of cancer patients in China and the

Related Keywords

China ,United States ,Stephen Spotts ,Protom International ,Protom International Holding Corporation ,Guohong Guokang Beijing Health Technology Development Co ,Sino Hope Group ,Office Of Protom International ,Guohong Guokang ,Proton Therapy System ,Chief Executive Office ,Licensing Agreement ,Chairman Zhang ,Tom International Holding Corporation ,Therapy System ,சீனா ,ஒன்றுபட்டது மாநிலங்களில் ,ஸ்டீபன் புள்ளிகள் ,சினோ நம்பிக்கை குழு ,ப்ரோடாந் சிகிச்சை அமைப்பு ,தலைமை நிர்வாகி அலுவலகம் ,தலைவர் ஜாங் ,டோம் சர்வதேச வைத்திருத்தல் நிறுவனம் ,சிகிச்சை அமைப்பு ,